5-minute read
CHSLD : pourquoi le privé fait-il mieux?
Entrepreneurial dynamism meets the demand for care for the elderly.
5-minute read
CHSLD : le privé dans le public, ça fonctionne
Entrepreneurial dynamism meets the demand for care for the elderly.
5-minute read
Les aînés bien logés et soignés grâce au privé
Entrepreneurial dynamism meets the demand for care for the elderly.
7-minute read
Relying on Entrepreneurs to House and Care for Our Seniors
It seems that each week brings its share of bad news about the Quebec health care system, to the point that we forget that certain of its components work rather well. This is the case for senior housing and care, largely provided by the private sector.
IEDM – Nouveaux médicaments; les malades attendent trop longtemps – Mathieu Bédard
April 10, 2018 | 14 min. 38 sec. | Boréale 138 (Ici Radio-Canada) Interview (in French) with Mathieu Bédard, Economist at the […]
4-minute read
Innovative drugs need a new regulatory approach
Access to new drugs in Canada.
IEDM – Pourquoi faut-il attendre pour avoir accès à de nouveaux médicaments? – Mathieu Bédard
April 5, 2018 | 26 min. 07 sec. | Isabelle (98.5 FM) Interview (in French) with Mathieu Bédard, Economist at the MEI, […]
IEDM – Nouveaux médicaments : les malades attendent 15 mois de trop – Mathieu Bédard
April 5, 2018 | 14 min. 36 sec. | Québec aujourd’hui (BLVD 102.1 FM) Interview (in French) with Mathieu Bédard, Economist at […]
5-minute read
Nouveaux médicaments : la longue marche réglementaire
Access to new drugs in Canada.
8-minute read
Innovative Drugs: A Bureaucratic Obstacle Course
Innovative drugs help people enjoy longer, healthier, more productive lives. They also allow our health care systems to save money. However, the reimbursement of new drugs by Canada’s public plans can face considerable delays due to a very burdensome regulatory process. Far from resolving this problem, a new reform will duplicate certain stages of this process and possibly lengthen it.